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Abstract
Objective The purpose of this review is to elucidate the
metabolic processes involved in the pathogenesis of ado-
lescent idiopathic scoliosis (AIS) in light of research by the
present authors as well as current literature.
Methods Pathogenetic mechanisms involved in AIS were
modeled as (a) a form of neuromuscular scoliosis (in
conjunction with an adverse mechanical environment such
as bipedality), in which hormonal and other chemical
factors act as regulators of skeletal muscle tone and
function; (b) as a consequence of an abnormality in growth
of the spinal column (in conjunction with an adverse
mechanical environment such as bipedality), in which
hormones and other chemical factors act as regulators of
growth; and (c) as a mechanical failure of one side of the
vertebral column due to a defect in trabecular formation or
mineralization (in conjunction with an adverse mechanical
environment such as bipedality); in which hormonal and
other chemical factors act as regulators of bone formation,
mineralization and/or resorption.
Results and conclusion Current evidence supporting
these models individually or in combination is discussed.
Keywords Adolescent idiopathic scoliosis  Melatonin 
Calmodulin  Estrogen  Bipedality
The etiology of adolescent ‘‘idiopathic’’ scoliosis
remains unresolved
Idiopathic scoliosis is a deformity of the torso that involves
all three planes of the body and is associated with lateral
deviation and axial rotation of the involved segments as
well as substantial lordosis if located in the thoracic spine.
Infantile and juvenile/adolescent idiopathic scoliosis (AIS)
need to be distinguished, because they are likely to be
distinct entities. Henceforward, the term ‘idiopathic’’ sco-
liosis is going to be used to deﬁne speciﬁcally AIS.
The search for an etiology of AIS may sound like an
oxymoron. However, to the best of our knowledge, idio-
pathic scoliosis is probably not as ‘‘idiopathic’’ as previ-
ously considered. Starting in the late 1960s, substantial
research efforts have been directed to investigate possible
mechanisms, none of which explain all the different facets
of this complex disease. A detailed overview of this
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it has been reviewed in detail in several recent articles
[1–5].
There is substantial evidence that there is a familial/
genetic background, but genetic studies have failed to
identify a single genetic locus or even a single chromosome
that contributes to AIS [3, 6]. These results may indicate
that AIS has a multifactorial etiology. Several theories and/
or factors have been proposed to explain the pathogenesis
of AIS, including connective tissue disorders, skeletal
muscle/contractile tissue disorders, hormonal perturba-
tions, developmental imbalance, abnormal vestibular and
proprioceptive systems, aberrant biomechanical factors,
uncoupled neuro-osseous growth, and dissociation between
the timing of skeletal and CNS maturation. Most, if not all
of these factors and conditions are likely present in indi-
viduals with AIS, and may either result from AIS, or par-
ticipate in disease onset and/or progression. Thus,
distinguishing the primary underlying pathogenetic fac-
tor(s) from the secondary and/or adaptive changes that
arise subsequent to the deformity itself is difﬁcult.
Melatonin deﬁciency: pinealectomized animal models
Pinealectomy as a model for scoliosis resembling that seen
in humans provides a system to investigate AIS experi-
mentally. Historically, the ﬁrst evidence of development of
scoliosis by pinealectomy and/or damage to the dienceph-
alon was provided by the work of Dubousset et al. [7]i n
the late 1970s and early 1980s. This area of research
remained dormant for almost a decade before being revi-
talized by the work of Machida et al. [8–13]. As a sum-
mary, this group has demonstrated that scoliotic deformity
can be consistently produced in chicken by pinealectomy if
the surgery is performed shortly after hatching. In fact,
pinealectomy resulted in a 100% rate of deformity in all
experiments if animals were rendered free of melatonin,
the major product of the pineal gland [4, 5, 14, 15]. Fur-
thermore, these investigators demonstrated that develop-
ment of scoliosis could be prevented by the re-implantation
of the pineal gland in skeletal muscle or by the adminis-
tration of melatonin as a replacement therapy [12]. In
addition to chicks, the scoliotic deformity can be produced
in pinealectomized rats as well (100% rate of deformity),
provided that they were forced to attain a bipedal posture
by amputation of the forelimbs and tails [16].
In line with these experimental ﬁndings, Machida et al.
[17] have also demonstrated that children with progressive
AIS had signiﬁcantly lower levels of blood melatonin when
compared to normal controls or those that have non-pro-
gressive AIS.
While serotonin (a precursor of melatonin) administra-
tion by itself is not very inﬂuential in the prevention of
deformity, probably because serotonin cannot cross the
blood brain barrier, 5-hydroxy-tryptophan (5HT), a sero-
tonin precursor that can cross the blood brain barrier, has
been shown to be effective in preventing the development
of scoliosis [13]. In further studies, Machida et al. [18] also
demonstrated that scoliosis would develop in a genetically
melatonin-deﬁcient strain of mice (C57Bl6) again at a rate
of 100% when those animals were made bipedal similar to
the rat model. Thus, these results indicate that the 5HT-
serotonin-melatonin pathway appears to be responsible for
the development of scoliosis in this model, and possibly in
humans as well.
Melatonin as a factor in AIS pathogenesis:
are the experiments repeatable?
Experimental data by other investigators have failed to
echo the ﬁndings of Machida et al. [15, 19–22]. Studies of
several other groups including Akel et al. have failed to
produce scoliotic deformity in pinealectomized chicken
with a rate of 100%, even when very low levels of blood
melatonin concentrations have been demonstrated. These
series reveal consistent rates of scoliotic deformity between
50 and 60% [14, 15, 20–23]. Likewise, rat and C57Bl6
mouse studies performed by us failed to demonstrate uni-
formity (i.e., 100% rate) in the development of scoliosis
[24, 25]. Furthermore, prevention of the appearance of
scoliosis by either melatonin administration or pineal gland
transplantation in chicken could not be replicated [19, 20].
These results raise the following questions:
1. What is the difference between the work of Machida
et al. and other investigations?
2. If very low levels of melatonin are produced in all
animals, why do not all animals develop scoliosis?
These questions are unanswered and suggest that other
factors may be involved in the pathogenesis of the scoliotic
deformity in this model.
Avian species including chicken have a very primitive
CNS compared to mammals, and the changes may affect
postural mechanisms. Therefore, the inception of a similar
model in animals with a more highly evolved CNS is
needed. In a study designed to analyze the effects of
pinealectomy in mammals (rodents), Bagnall et al. [26]
could not produce scoliosis in quadrupedal animals (0%
rate). As a result, despite overwhelming evidence provided
by Machida et al. [20], and data supporting the fact that the
development of scoliosis is not an artifact of the surgical
procedure per se, there is still controversy regarding the
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the development of scoliosis in higher animals.
In addition to the controversy among animal models,
there is also considerable controversy regarding the blood
melatonin levels of human AIS patients and the potential
implications of serum melatonin levels on the treatment of
AIS. Machida et al. [17] have claimed to demonstrate
signiﬁcantly lower levels of blood melatonin concentration
in scoliotic patients with progressive disease which in turn
may be reversed by the administration of melatonin, but
other studies have disputed the very possibility of detecting
low serum melatonin levels in adolescents with AIS [27].
As a summary, it appears that the theory suggesting the
very decrease or lack of melatonin in the bloodstreams of
affected individuals should be the cause of AIS may be
overly simplistic and clinically unproven.
On the other hand, it is almost certain that melatonin
and/or another product of the pineal gland may be involved
in a number of pathogenetic pathways contributing to the
development of AIS. Genetic association studies have
demonstrated that a polymorphism in the melatonin
receptor 1B (MTNR1B) gene [28] but not melatonin
receptor 1A (MTNR1A) gene [29] is associated with the
occurrence of AIS. Other studies have demonstrated that
there is a defect in melatonin signaling in the osteoblasts of
patients with AIS [30] and this defect caused an increased
phosphorylation of the serine residues affecting the activity
of inhibitory G proteins (Gi) normally associated with
melatonin cell surface receptors [31]. Indeed, Moreau et al.
have shown experimentally that all Gi (G inhibitory)-cou-
pled receptors are affected in different cell types isolated
from AIS patients demonstrating that AIS etiology goes
way beyond the classical view that AIS is caused by
melatonin deﬁciency or a pre-existing melatonin signaling
defect (Moreau et al, unpublished data, proceedings of the
annual meeting of Yves Cotrel Foundation, 2009).
Of note, there is also data that demonstrates abnormali-
ties in the expressions of Ca
2?ATPases (SERCA; sarco/
endoplasmic reticulum Ca
2?ATPase and PMCA; plasma
membrane Ca
2?ATPase) in platelets as well as in osteo-
blasts of scoliotic patients, suggesting a defect in cell dif-
ferentiation involving caspase-3 (i.e., the apoptosis-like
phase of the differentiation) [32]. Calmodulin regulates this
system. SERCAs pump Ca
2? ions into the endoplasmic
reticulum (ER), i.e., control the amount of Ca
2? into the
ER. The ER is a multifunctional organelle supporting many
functions and is known to be involved in protein synthesis,
translocation across the membrane, integration into the
membrane, and posttranslational modiﬁcation. PMCAs
extrude Ca
2? from the cytosol and are key molecular
components of cellular Ca
2? homeostasis and signaling.
Changes in Ca
2? signaling and handling control muscle
development, neuronal precursor differentiation, and
osteoblast growth and differentiation [33]. According to
this paradigm, melatonin treatment of MEG01 cells
(platelet precursor megakaryocytic cell line) results in a
dose-dependent increase in Ca
2?ATPase expression
(SERCA3 and PMCA) as well as caspase 3 activity.
Therefore, it appears to be an association with melatonin
(and/or calmodulin) in the etiopathogenesis of AIS but the
actual mechanism(s) of the development of deformity
remains unclear.
Work by Acaroglu et al. [34] and other researchers
suggest that these interacting mechanisms may well be, but
not limited to:
• AIS modeled as a form of neuromuscular scoliosis (in
conjunction with an adverse mechanical environment
such as bipedality); in which hormonal and other
chemical factors act as regulators of skeletal muscle
tone and function,
• AIS modeled as a consequence of an abnormality in
growth of the spinal column (in conjunction with an
adverse mechanical environment such as bipedality); in
which hormones and other biochemical factors act as
regulators of growth,
• AIS modeled as a mechanical failure of one side of the
vertebral column due to a defect in trabecular formation
or mineralization (in conjunction with an adverse
mechanical environment such as bipedality); in which
hormonal and other chemical factors act as regulators
of bone formation, mineralization and/or resorption.
AIS modeled as a form of neuromuscular scoliosis
Melatonin as a regulator of muscle tone
With the advent of radioactive labeling, melatonin recep-
tors in peripheral tissue can be studied in picomolar
afﬁnities and femtomolar densities, revealing their pres-
ence in the gastrointestinal system, kidney, lung, heart, vas
deferens, and blood vessels [35]. Later research has dem-
onstrated that melatonin was effective in the modulation of
vascular smooth muscle tone [36], and intestinal smooth
muscle tone [37]. There is also experimental evidence that
melatonin and 5-HT4 can affect contractility of chick
myocardiocytes in culture [38]. These ﬁndings suggest that
melatonin or 5-HT4 receptors may play an important role
in the modulation of the tone of skeletal muscles as well,
which in turn may explain the occurrence of spinal defor-
mity in pinealectomized animals. A review by Pompeiano
et al. [39] have suggested a similar association in humans,
i.e., the decreased activity of melatonin as well as 5-HT
may result in a decrease in the tonus of postural skeletal
muscles and may be very important in the pathogenesis of
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could lead to an increase or decrease in other regulatory
protein(s). An analysis of the regulation of melatonin
secretion suggests that calmodulin is the neurotransmitter
that is effective in turning melatonin secretion on and off
[40].
Calmodulin: what is the signiﬁcance in AIS?
Calmodulin is a calcium-binding receptor protein that
regulates cAMP-based enzyme systems. Calmodulin reg-
ulates the contractile properties of muscle cells by con-
trolling calcium transport through the cell membrane [41],
and calmodulin also interacts directly with the contractile
proteins, actin and myosin, within the myoﬁber. Platelet
function anomalies were identiﬁed in AIS patients long ago
[42] but the actual relationship with the spinal pathology
still remains to be established. Platelets in patients with
AIS have elevated levels of Ca
2? and P
i? [43, 44],
decreased activity of intracellular contractile proteins [43,
45], decreased aggregation [26, 46] and abnormal structure
of myosin [43]. Interestingly, several studies have dem-
onstrated that intracellular calmodulin levels are also
increased, especially in patients with progressive idiopathic
scoliosis [47, 48]. Further studies on platelets performed by
Bredoux et al. demonstrated that the expression of
Ca
2?ATPases which regulate the megakaryocytopoiesis
(platelet maturation) as well as osteoblast differentiation is
abnormal in scoliosis. Further, decreased melatonin levels
could account for the abnormality in platelets, because
melatonin causes megakaryocyte fragmentation and mod-
ulates the cytokine network involved in platelet production
[32]. As platelets are thought to resemble ‘‘miniature ver-
sions of skeletal muscle cells’’, these ﬁndings suggest that
abnormalities in paravertebral muscles of patients with AIS
could be primary factors in development and/or progres-
sion of spinal deformities. In fact, Zhao et al. [49] had
demonstrated that in AIS patients, the expressions of cal-
modulin and neuronal nitric acid synthase (nNOS) were
signiﬁcantly lower in the paravertebral muscles of the
convex side of the deformity. Identiﬁcation of a relation-
ship between calmodulin activity in platelets and calmo-
dulin activity in paravertebral skeletal muscles may provide
a better understanding of mechanisms underlying develop-
ment and progression of AIS. Hypothetical neuromuscular
mechanism caused by the disruption in the balance between
melatonin and calmodulin is represented in Fig. 1.
Previous studies by Acaroglu et al. and Akel et al. [24,
34, 50] on the same theme consisted of three different
projects to help deﬁne the signiﬁcance of melatonin and
calmodulin in the pathogenesis and mechanisms of scoli-
osis. In the ﬁrst, tissue levels of melatonin and calmodulin
were measured in platelets and skeletal muscle derived
from patients with adolescent idiopathic scoliosis under-
going surgical treatment and compared to a group of
patients with no underlying chronic spinal problem [34].
Results of this study revealed that contrary to previously
published reports, tissue calmodulin levels were not sig-
niﬁcantly different in scoliotics compared to controls, a
ﬁnding that indicates platelet calmodulin levels may not be
adequate to use as a screening tool for the impending onset
of scoliosis. Likewise, tissue melatonin concentrations
were not signiﬁcantly different in scoliotics compared to
controls. Based on these ﬁndings, it may be postulated that
in accordance with the studies demonstrating no differ-
ences in serum levels, there are probably no differences in
tissue levels as well. Furthermore, it was also demonstrated
that skeletal muscle calmodulin content was signiﬁcantly
different when the convex side was compared to the con-
cave side. However, contrary to the ﬁndings of Zhao et al.
cited above [49], the results of Acaroglu et al. showed an
increase of muscle calmodulin levels at the convex side.
This is an important ﬁnding as it demonstrates that cal-
modulin may be involved in the regulation of contraction
of skeletal muscles and electrophysiological differences
between these muscles may reﬂect differences in calmod-
ulin concentration.
Although calmodulin is probably not a causative factor,
this molecule may be one of the important factors con-
tributing to the progression of scoliotic curves. In other
words, it may be hypothesized that calmodulin is probably
not the factor triggering the occurrence of deformity but the
secondary imbalance in calmodulin content may be the
factor governing progression [34].
This hypothesis was tested in two other studies using
animals models, a pinealectomized chicken model and a
C57Bl6 mice model, attempting to antagonize calmodulin
using two different CaM antagonist pharmacological
agents, tamoxifen (TMX) and triﬂuoperazine (TFP) [24,
51] (In fact, an earlier study by Enouf et al. [51] has shown
that TFP inhibited the Ca
2? transport mediated by
Ca
2?ATPases in microsomal platelet fractions). Findings
of these studies demonstrated that as hypothesized, cal-
modulin inhibitors do not prevent the occurrence of
Calmodulin Melatonin
Muscle contractility Muscle contractility
Neuromuscular instability
Calmodulin ?
Fig. 1 A schematic explanation of the neuromuscular ‘‘hypothesis’’.
Both being shown as muscle tone regulators, any change in the
balance between melatonin and calmodulin may effects muscle
contractility thereby causing neuromuscular imbalance
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or the C57BL6 mice models. On the other hand, TMX was
shown to decrease the rate of progression of deformity in
both models. This observation suggests that the hypothesis
on the inﬂuence of calmodulin on the progression of the
deformity may be correct. In addition, in both models,
tamoxifen with or without the addition of triﬂuoperazine
led to the reversal of curvature in a signiﬁcantly higher
number of animals compared to controls. Interestingly,
TMX and raloxifen (RLX) appear to have a negative effect
on the smooth muscle tone of vascular walls as well [52]
and their mechanism of action in the reversal of deformity
in animal models may be based on this effect. However, it
has to be stressed that the action of TMX might not have
necessarily been based on its’ affect on calmodulin but by
way of a different interaction, speciﬁcally the regulatory
effect on estrogen or estrogen regulated proteins.
AIS modeled as a local defect in the growth
of the spinal column
The natural history of adolescent idiopathic scoliosis is
strongly associated with growth. Clinically, it can easily be
claimed that this is an ascending (increasing/growing) type
of scoliosis (as opposed to the descending/collapsing types
such as neuromuscular or degenerative) as the initiation of
the deformity is during a period of very rapid growth.
Similarly, progression of spinal curves is closely interre-
lated with the actual rate of growth, as well as, with the
remaining potential of growth in affected individuals. This
phenomenon of dependency on growth is also evident in
the animal models discussed above, because there is no
evidence suggesting that experimental models of scoliosis
can also be developed in mature animals.
It is a common knowledge that certain types of spinal
deformity such as ‘‘congenital deformity’’ arise from the
growth imbalance within the vertebral column; emerging
as scoliosis if the asymmetry is predominantly in the
coronal plane, as kyphosis or more rarely as lordosis if in
the sagittal plane; or as kyphoscoliosis in case it is in both
planes. It is plausible that similar growth plate abnormal-
ities may be present in patients with idiopathic scoliosis as
well. An MRI study by Day et al. [53] suggest abnormal-
ities albeit similar at the concave and convex sides of the
growth plates, suggesting a primary disturbance of growth
as a potential cause for the development of deformity.
Likewise, Rusova et al. [54] demonstrated a signiﬁcant
decrease in sulfation and acetylation of glycosaminogly-
cans suggesting a primary defect in the function of cells in
the growth plates. However, histomorphological studies of
vertebral endplates obtained from animal models of scoli-
osis as well as human subjects have only demonstrated
evidence suggesting that uneven loading leads to differ-
ences in cell proliferation [55], cell differentiation [44] and
changes in collagen composition [56], but they failed to
show any hint of a primary disturbance of growth.
Another possible mechanism in which a problem of
growth may be associated could be a defect in the modu-
lation of growth in patients with AIS. Indeed, genetic
studies suggest several single nucleotide polymorphisms
(SNPs) in genes coding proteins that regulate growth may
be associated with the development or progression of
scoliosis in AIS [57–59]. These SNPs may also be asso-
ciated with the generalized osteopenia in AIS patients [57]
(see discussion below). Qiu et al. [60] demonstrated a
signiﬁcant decrease in circulating leptin levels in patients
with AIS, which is associated with altered growth param-
eters and changes in bone mineral density/content (BMD/
BMC). More recently, Liu et al. [61] measured serum
leptin and sOB-R concentrations by enzyme-linked
immunosorbent assay (ELISA) and showed that AIS girls
were found to have signiﬁcantly higher sOB-R level and
lower free leptin index (FLI) after adjusting for age and
body weight in multivariate regression analysis. Finally,
unpublished data by Moreau et al. suggest that increased
activity of certain cytokines may be associated with the
development and progression of scoliosis in melatonin
deﬁciency animals (pinealectomized chicken and C57BL6
mice), as well as, in AIS patients (Moreau, unpublished
data, proceedings of the annual meeting of Yves Cotrel
Foundation, 2009). In conclusion, there is evidence sug-
gesting the presence of a growth disturbance in patients
with AIS, but this domain remains to be the least explored
of the hypothetical mechanisms listed above.
AIS modeled as a mechanical failure of one side
of the vertebral column due to a defect in trabecular
formation or mineralization
The clinical association of AIS with osteopenia was
brought to attention by the work of Cheng et al. [62–65].
Although it was assumed that this ﬁnding might be the
consequence of a problem in vitamin D synthesis or
metabolism, no defects in this system or appropriate
genetic polymorphisms could be identiﬁed [66, 67].
Unpublished pilot data by Acaroglu et al. on the bipedal
C57Bl6 model also suggests that the animals with scoliosis
have signiﬁcantly less trabecular density compared to those
animals that received TMX treatment. In an effort to
replace TMX with a more speciﬁc selective estrogen
receptor modulator (SERM) RLX, this group demonstrated
that RLX was as effective as TMX in inducing regression
of scoliotic curves in the mouse model, and also that
administration of pharmacological agents after the
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model) might be almost as effective as the preemptive use.
Based on these observations another study was per-
formed in which osteoporosis was investigated as the pri-
mary factor in the development of experimental scoliosis.
In this study, we compared the frontal and sagittal spinal
alignment in bipedal rats rendered osteoporotic with sub-
cutaneous heparin injections compared to controls. Results
of this study [25] failed to demonstrate any signiﬁcant
differences in rates of scoliosis, nor of curve magnitudes.
However, it was very interesting to see that the majority
of non-melatonin-deﬁcient bipedal animals did develop
deformity, more so when they were osteoporotic. Another
signiﬁcant ﬁnding of this study was a signiﬁcant decrease
in the amount of kyphosis in the osteoporotic group, which
is consistent with the clinical observations in human
patients with AIS. This ﬁnding is unique in the sense that
the sagittal plane had not been evaluated in the previous
studies and may be very important in our understanding of
the three dimensional scoliotic deformity in these models.
However, these ﬁndings do suggest that SERM, such as
TMX and RLX may be effective in the reversal of osteo-
penia and scoliotic deformity in animal models. In other
words, although the experiments with these molecules were
started with the assumption that their CaM antagonism had
been the mechanism of action, results suggest that estrogen
receptor modulation may be the key factor in the observed
effects; especially considering that RLX probably does not
have any anti-CaM properties.
These observations suggest that estrogen and/or estro-
gen receptors may be key factors in the pathogenesis of
AIS. This assumption indeed makes clinical sense as it may
explain the female predilection associated with the disease.
Furthermore, it may also explain the observation of oste-
openia in scoliotic individuals, potentially similar to the
osteopenia observed following menopause. Estrogen
receptor gene polymorphism has been recognized to be
associated with AIS in humans in work by Inoue and by
Moldovan et al. [67]. Research by Dr Moldovan’s labora-
tory has shown that estrogens play a critical role in AIS
[68, 69] through their impact on bone cell signaling and
function. Their results indicate that estrogens are not at the
origin of AIS; however, they interact with the osteoblast
signaling defect in AIS patients. Indeed, estrogens are
known to repress and reduce the synthesis of G proteins
both at the transcriptional and translational levels. In this
respect, Moreau et al. have proposed a model explaining
the incidence of AIS around puberty and why girls are
more affected in number and severity due to a cross-talk
between estrogens and the pre-existing melatonin signaling
defect in AIS [70]. Moldovan et al. [31, 70] has previously
demonstrated that 17-b-estradiol can reduce cAMP pro-
duction in a speciﬁc subgroup of AIS patients identiﬁed
according to the functional classiﬁcation of Moreau et al.
[31, 70], i.e., melatonin-responsive AIS patients. In this
work, the molecular mechanism whereby this reduction
occurs was characterized. The melatonin receptor MT2,
which is normally physiologically coupled with the Gi
protein, switches to the Gs protein in the osteoblasts of a
speciﬁc group of AIS patients when their cells are exposed
to 17-b-estradiol. Effect of estrogens on osteoblast
metabolism is well documented in the literature and in
clinical practice, but curiously, little was known regarding
AIS. Osteoblast differentiation impacts the rigidity, elas-
ticity, and mechanical properties of bone, involving an
increase in alkaline phosphatase (ALP) activity, extracel-
lular matrix (ECM) synthesis, and bone mineralization, and
an existing defect of this was also observed. It is well
known that estrogens promote high AP activity, collagen
synthesis and calcium deposition in bone ECM. In these
studies, it was veriﬁed the osteoblastic phenotype of cells
derived from bone biopsies, but the effect of 17-b-estradiol
on osteoblast gene markers for differentiation (osteocalcin,
osteopontin, BSP, and ALP activity) could not be demon-
strated. However, these effects have been clearly estab-
lished in many studies, and it is widely accepted that
estrogen depletion reduces osteoblast activity. This impacts
the balance between the resorption and formation of bone,
and can lead to osteopenia present in AIS patients as dis-
cussed above.
The common denominator: bipedality
Clinical observations and animal models suggest that the
common denominator in the occurrence of scoliosis may be
bipedality. To date, scoliosis can be neither experimentally
produced nor observed naturally in any quadrupedal ani-
mal. Our previous work discussed above also suggests that
bipedality is essential for the production of scoliosis [25].
In 2005, Castelein et al. [71] offered a possible explanation
of the association between bipedality and the development
of scoliosis. These investigators suggest a shift of the
moments acting on the spinal column from being purely
ﬂexor in the quadrupedal animals to being dominantly
extensor in humans standing upright [71–73]. This extensor
moment may unlock the facet joints that are very effective
in resisting the anterior translation but not so in resisting
the posterior translation of one vertebra over the other. The
resulting instability may in turn produce a rotational
deformation of the involved functional unit, triggering the
onset of scoliotic deformity [73]. This theory also explains
the fact that AIS is almost unique to humans as the bipe-
dality of other primate species is not associated with the
same upright posture. In fact, apart from humans there is
only one case report of an orangutan with scoliosis that was
1038 Eur Spine J (2012) 21:1033–1042
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to a CNS infection [74].
Of note, it has recently been postulated that scoliosis
may also be initiated in several ﬁsh species including sal-
mon [75] and a wider group of teleosts [76] after pineal-
ectomy. In their study, Fjelldal et al. [75] have
demonstrated that the development of scoliosis in pinea-
lectomized salmon was associated with a decreased BMC,
decreased stiffness, yield limit and resilience of the verte-
bral bodies which may in turn yield to the massive body
musculature of the ﬁsh. This ﬁnding is important because it
demonstrates that pinealectomy in ﬁsh also causes osteo-
penia and related mechanical problems of the spine. In
addition, the massive body musculature of the ﬁsh might be
exerting an axial force comparable to gravity in humans
(i.e., ﬁsh models of spinal loading might be more appro-
priate than quadruped animal models).
The effects of bipedality are probably not limited to
deformities in the coronal plane of the spinal column but
other planes have not been investigated in animal models to
date. In addition, possible structural changes in the pelvis
and spinopelvic junction in spinal columns with or without
any scoliotic deformity are virtually unknown. It is rea-
sonably probable that especially in the experimental animal
models, the initiation of scoliotic deformity may be sec-
ondary to an extensor or rotational moment that may trig-
ger the scoliotic deformity in susceptible animals as a
consequence of a metabolic or hormonal disorder (as out-
lined above). For this reason, it may be very important to
analyze the metabolic and/or endocrine factors in
conjunction with the postural factors in the absence of
which no deformity would develop (Fig. 2).
Future work
Analysis of the structural as well as biochemical changes in
the spinal columns of experimental bipedal animals would
also shed light on the origins of degenerative problems of
the spinal column in humans. These studies may answer
some of the following fundamental questions:
1. Do the ﬁndings in animal models reﬂect similar
pathologies in humans, and likewise, do the ﬁndings
in animal models reﬂect pathologies in humans?
2. Assuming that pinealectomy or other anti-melatonin
interventions produce similar biochemical and hor-
monal consequences, why is it that all bipedal
melatonin-deﬁcient animals do not produce scoliosis?
The explanation for this may be mechanical or postural
and might be identiﬁed with the analysis of the three-
dimensional spinopelvic parameters of these animals,
or may be based on the fact that our assumption above
is indeed wrong.
3. Do the growth and/or mechanical problems (i.e.,
osteopenia) associated with scoliosis develop before
or secondary to the occurrence of scoliotic deformity?
With the possibility of analyzing the spinal columns in
3D at the time of histomorphometric analysis, the

































Fig. 2 A schematic explanation
of the interaction between
genetic, metabolic and
mechanical (postural) factors in
the development of scoliosis.
Please note that (1) scoliosis
may follow various mechanistic
pathways to develop in different
individuals and (2) the genetical
background of these pathways
may be present in the majority
of the general population while
only outliers (i.e., individuals
with several factors) are
affected
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123mechanical disturbance as well as that producing the
deformity may be identiﬁed.
4. Which pharmacological agents (TMX, RLX, estrogen,
NO donors) administered may be effective in arresting
and/or reversing the deformity? At which time
point(s) are they effective, and upon which mechanism
do they act?
5. With the understanding that we are not at the point of
identifying the exact etiology of AIS, could we
possibly identify the pathological mechanisms effec-
tive in the occurrence and progression of the defor-
mity, and based on this, could we treat AIS in humans
with pharmacological agents?
6. Finally, if the mechanisms associated with occurrence
and progression is predominantly mechanical in some
individuals (animals) and biochemical in others, can
we identify these subsets in order to treat one group
with mechanical measures (this group may be more
amenable to brace treatment), and the other with
hormonal/pharmacological measures (assuming this
group will be more resistant to brace treatment)?
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